Patent risk There are ongoing patent infringement litigation concerns involving True Wearables, including past cases with Masimo. Sales teams should approach medical device customers with clear messaging about IP status, risk mitigation, and potential licensing or collaboration discussions.

Disposable low cost The company emphasizes low-cost, fully disposable, wireless devices. This positions True Wearables well for price-sensitive markets and settings requiring single-use devices, suggesting opportunities with end users in ambulatory care, home health, and field applications.

Oxxiom leadership Oxxiom is their flagship product offering continuous noninvasive cuffless blood pressure measurement and has won prestigious design awards. This can be leveraged to target premium or design-conscious adopters and institutions seeking innovative monitoring solutions.

Small team agility With a lean employee base and revenue under one million, True Wearables may be open to OEM partnerships, white-label arrangements, or distributor channels to scale distribution without substantial internal expansion.

Strategic markets Past press and product focus on sports, aviation, and medical devices indicates potential cross-sell opportunities to patient monitoring, anesthesia, or sport science programs, as well as collaborations with clinics that require continuous peripheral blood pressure monitoring.